Management of aggressive pituitary adenomas: current treatment strategies.
about
Genetically engineered mouse models of pituitary tumorsOverexpression of EpCAM and Trop2 in pituitary adenomasO-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysisA consensus on the diagnosis and treatment of acromegaly complications.Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up.MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro.The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.Treatment of pituitary neoplasms with temozolomide: a review.Therapy of aggressive pituitary tumors.Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.Temozolomide in aggressive pituitary adenomas and carcinomas.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Aggressive tumors and difficult choices in acromegaly.Aggressive pituitary adenomas--diagnosis and emerging treatments.Progress in the Diagnosis and Classification of Pituitary Adenomas.The safety of treatments for prolactinomas.Management of aggressive growth hormone secreting pituitary adenomas.Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.Nonfunctioning giant pituitary adenomas: Invasiveness and recurrenceExtended endoscopic transplanum-transtuberculum approach for pituitary adenomas.Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma.Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions.
P2860
Q33984418-B8B38435-A80B-42E8-A486-BD30B95C33D8Q34733193-FF3FFB46-0CBD-4E04-B54E-D45F14D770F6Q36268061-EB3CFFB1-ED77-40A3-87D1-29ADB308FF7AQ37061155-4C77727B-C8CA-494D-9960-33B7E2888FDCQ37222927-56C0BD51-5043-495C-A362-F747E8FA1BE8Q37714078-0062B374-E664-4DFB-B676-49DB5CF7E297Q37716067-3E274683-4276-427E-BB4C-0F3BCBDB00E9Q37789267-1F503AB9-F3BB-4AEE-B4D8-FCF9E2A052BEQ37857296-52D7D369-4D0B-47F0-8A79-692E09F84B66Q37865580-6F37F487-28EC-4C73-9D01-942C3D523562Q37955091-BAB1A260-2A97-4DFC-B7FE-662E3C3CF74DQ37992191-52BE22A0-0310-4DBF-BAD8-869BC130835DQ38010032-95BAB54B-69C8-48B8-830D-EDA2601808E4Q38107011-3A8ED7F7-58D2-43F5-ADCE-FA2075B65824Q38167711-3D4A55A6-0F71-44B6-B991-A63C18F56259Q38211375-3062473B-A29C-4420-8741-C8DE46D70793Q38540507-4E76D34E-E24B-45AD-B7F8-B773A0E88F1AQ38726058-1AF09D53-59C9-4412-B6B4-640B9C23440DQ38781620-22EF3CCD-970C-44F4-9C05-572658B50B01Q39151286-7ADA54A1-5E64-46EF-9A4B-34B7841D9068Q42253575-06CBB87D-2ED8-4752-97B2-793D6F287AF8Q44565582-BE012DA7-05E1-4A33-ADAB-A04B01B7F761Q44926164-2A81E867-EE2A-4E43-B381-5F5E89FBF86AQ48366708-6A46DACC-8916-4B71-A95A-3993180534AEQ48500442-6D47B970-AD95-4F11-A3AB-25CE93765078Q55370601-2D722B53-44AB-4402-B83D-7941352DC581
P2860
Management of aggressive pituitary adenomas: current treatment strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of aggressive pituitary adenomas: current treatment strategies.
@en
Management of aggressive pituitary adenomas: current treatment strategies.
@nl
type
label
Management of aggressive pituitary adenomas: current treatment strategies.
@en
Management of aggressive pituitary adenomas: current treatment strategies.
@nl
prefLabel
Management of aggressive pituitary adenomas: current treatment strategies.
@en
Management of aggressive pituitary adenomas: current treatment strategies.
@nl
P1433
P1476
Management of aggressive pituitary adenomas: current treatment strategies.
@en
P2093
Michael Buchfelder
P2888
P304
P356
10.1007/S11102-008-0153-Z
P577
2009-01-01T00:00:00Z